AnaptysBio (ANAB)
(Delayed Data from NSDQ)
$23.95 USD
-1.06 (-4.24%)
Updated May 21, 2024 04:00 PM ET
After-Market: $23.88 -0.07 (-0.29%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-1.34 | 1.37% |
Earnings Summary
For their last quarter, AnaptysBio (ANAB) reported earnings of -$1.64 per share, missing the Zacks Consensus Estimate of -$1.54 per share. This reflects a negative earnings surprise of 6.49%. Look out for ANAB's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$1.34 per share, reflecting a year-over-year increase of 10.67%.
Earnings History
Price & Consensus
Zacks News for ANAB
Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Tops Revenue Estimates
ANAB: What are Zacks experts saying now?
Zacks Private Portfolio Services